Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STAT3 Antibody, KO Validated | Login | STAT3 Antibody, KO Validated | ||||||||||||||||
|
||||||||||||||||||
| BAX Antibody, KO Validated | Login | BAX Antibody, KO Validated | ||||||||||||||||
|
||||||||||||||||||
| HSP90AB1 Antibody | Login | HSP90AB1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| EGFR Antibody | Login | EGFR Antibody | ||||||||||||||||
|
||||||||||||||||||
| SQSTM1 / p62 Antibody | Login | SQSTM1 / p62 Antibody | ||||||||||||||||
|
||||||||||||||||||
| EGFR Antibody | Login | EGFR Antibody | ||||||||||||||||
|
||||||||||||||||||
| YAP1 Antibody | Login | YAP1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| p38 MAPK Antibody [H8B1] | Login | p38 MAPK Antibody [H8B1] | ||||||||||||||||
|
||||||||||||||||||
| AKT1 Antibody | Login | AKT1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| beta Catenin Antibody | Login | beta Catenin Antibody | ||||||||||||||||
|
||||||||||||||||||
| ARRB1 Antibody [F7C2] | Login | ARRB1 Antibody [F7C2] | ||||||||||||||||
|
||||||||||||||||||
| BAK1 Antibody [48A10] | Login | BAK1 Antibody [48A10] | ||||||||||||||||
|
||||||||||||||||||
| BCL10 Antibody, KO Validated | Login | BCL10 Antibody, KO Validated | ||||||||||||||||
|
||||||||||||||||||
| FAK Antibody [E1E5] | Login | FAK Antibody [E1E5] | ||||||||||||||||
|
||||||||||||||||||
| ROCK1 Antibody [H5E4] | Login | ROCK1 Antibody [H5E4] | ||||||||||||||||
|
||||||||||||||||||
| ANXA1 Antibody, KO Validated | Login | ANXA1 Antibody, KO Validated | ||||||||||||||||
|
||||||||||||||||||
| ERK2 Antibody, KO Validated | Login | ERK2 Antibody, KO Validated | ||||||||||||||||
|
||||||||||||||||||
| beta Catenin Antibody, KO Validated | Login | beta Catenin Antibody, KO Validated | ||||||||||||||||
|
||||||||||||||||||
| RALBP1 Antibody, KO Validated | Login | RALBP1 Antibody, KO Validated | ||||||||||||||||
|
||||||||||||||||||
| BAX Antibody, KO Validated | Login | BAX Antibody, KO Validated | ||||||||||||||||
|
||||||||||||||||||
| HNRNPA2B1 Antibody, KO Validated | Login | HNRNPA2B1 Antibody, KO Validated | ||||||||||||||||
|
||||||||||||||||||
| PML Antibody, KO Validated | Login | PML Antibody, KO Validated | ||||||||||||||||
|
||||||||||||||||||
| DES Antibody | Login | DES Antibody | ||||||||||||||||
|
||||||||||||||||||
| PRKCA Antibody [45F9] | Login | PRKCA Antibody [45F9] | ||||||||||||||||
|
||||||||||||||||||
| Caspase 9 Antibody [A7C3] | Login | Caspase 9 Antibody [A7C3] | ||||||||||||||||
|
||||||||||||||||||


